market analyst,, market analyst llc, market research & analyst

Payment Options

  Home > Industry > Healthcare & Pharmaceuticals > Companies - Healthcare & Pharmaceuticals >

Telemedicine and M-Health Push to Talk Smart Phones: Markets Reach $4.4 Billion By 2019
Telemedicine and M-Health Push to Talk Smart Phones:   Markets Reach $4.4 Billion By 2019



Publisher: Wintergreen Research
Publication: Date: 11/12/2013
Delivery Format: EPUB,Mobi

Product Code: WG-131112

License types*:

LEXINGTON, Massachusetts (November 12, 2013) – WinterGreen Research announces
that it has published a new study Push to Talk Tele-Medicine and M-Health Market
Shares, Market Strategy, and Market Forecasts, 2013 to 2019.  The 2013 study has 791
pages, 278 tables and figures.  Worldwide markets are poised to achieve significant
growth as the push to talk is used inside telemedicine systems and m-health initiatives as
a way to implement ruggedized handset communications for all clinicians.

Worldwide Tele-medicine and M-health PTT push to talk device market driving forces
relate to an overall trend toward clinical reimbursement addressing mobile health
initiative for chronic conditions.  This trend promises to become prevalent as people learn
how to keep themselves healthier.  Healthy behaviors such as exercise, good diet and
stress management have the potential to reverse aging on a molecular level and partly
restore the vitality of a person's cells.

Healthy lifestyle choices can increase the length of DNA sequences found at the end of a
person's chromosomes.  This shift toward wellness has stimulated the need for better
communication between clinicians and patients.  New sensor technology creates the
opportunity for monitoring and for alerts to be send to and from at risk people who are

PTT telemedicine markets are poised to achieve significant growth as the existing
telemedicine systems merge with the smart phone systems of engagement to provide a
way to improve clinical care delivery to patients with chronic disease, decreasing
hospitalizations and visits to the emergency room.  There is a convergence of
telemedicine and m-health as the patients become more responsible for their own care
delivery and their own health.  
There is a convergence of telemedicine and m-health as the patient uses push to talk
devices in telemonitoring situations where the sensor data is transmitted to a facility,
encouraging the patient to become more responsible for their own care delivery and their
own health.  Push to talk devices are more rugged than ordinary smart phones and are
used in transport situations inside the hospital and in ambulances.  
Healthcare patient, physician, and facility decision support markets are forecast based n
the broad availability of smartphones combined with the IBM Watson technology that
Watson offers Interactive Care Insights for Oncology. The cognitive systems use insights
gleaned from the deep experience of Memorial Sloan-Kettering clinicians. Watson is
positioned to permit clinicians to provide individualized treatment.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared
the telemedicine market research study, “Telemedicine push to talk PTT markets are
evolving as smart phone devices find more uses during patient transport.  During
emergency transport, sensors can provide monitoring that has not previously been
available.  Differential diagnostic tools support differential tele-medical treatment.  The
decision process take into account clinical findings form the home monitoring devices
and from symptoms verbally communicated in a clinical services implementation.”

Both tele-medicine and m-health contribute to healthcare delivery in the home.  M-health
will surely be delivered over the smart phone.  Tele-medicine is evolving toward smart
phone device delivery as well.  The cost of tele-medicine for the US veterans
administration is $1,600 per patient per annum.  This is substantially less than other NIC
programs and nursing home care which can easily run to $100,000 per annum.  VHA's
experience is that an enterprise-wide home tele-medicine implementation is an
appropriate and cost-effective way of managing chronic care patients in both urban and
rural settings.

Chronic disease conditions are best treated early on when there is a change in patient
condition and an early intervention can make a difference.  It is even better to treat them
in a wellness treatment environment before there are indications of chronic disease,
before symptoms develop, by addressing lifestyle issues early on.

Telemedicine delivered on proprietary devices is becoming obsolete.  Kyocera is the
market leader in push to talk phones for telemedicine.  The Honeywell / Samsung
strategic alliance represents the smart phone model that works.  Telemedicine market
analysis indicates that the price points are way below device costs and that companies are
seeking to gain market share by working with clients.  

Telemedicine push to talk PTT dedicated device and software markets at $214 million in
2012 are anticipated to reach $4.4 billion by 2019.  M-Health markets related to
telemedicine at $1.4 billion are anticipated to reach $1.5 trillion by 2019 due to the
leveraging of 8.5 billion smart phones and 5 billion connected tablet devices all over the

WinterGreen Research is an independent research organization funded by the sale of
market research studies all over the world and by the implementation of ROI models that
are used to calculate the total cost of ownership of equipment, services, and software.  
The company has 35 distributors worldwide, including Global Information Info Shop,
Market, Research and Markets, Electronics.CA, Bloomberg, and
Thompson Financial.  
WinterGreen Research is positioned to help customers face challenges that define the
modern enterprises. The increasingly global nature of science, technology and
engineering is a reflection of the implementation of the globally integrated enterprise.  
Customers trust WinterGreen Research to work alongside them to ensure the success of
the participation in a particular market segment.
WinterGreen Research supports various market segment programs; provides trusted
technical services to the marketing departments.  It carries out accurate market share and
forecast analysis services for a range of commercial and government customers globally.  
These are all vital market research support solutions requiring trust and integrity.
Keywords: Chronic heart failure, CHF, Chronic heart disease, Telehealth, Telemedicine, Telemonitoring, CMS
Telemonitoring, Heart disease treatment efficacy, Care Management, CMHCB, Health Buddy System, Medicare
Monitoring, Remote patient monitoring, Heart failure mortality, Health economics, Heart Failure, Heart Diseases,
Cardiovascular Diseases, Behavior CHF patient, Behavior Modification, Telemedicine, Hypertension monitoring,
chronic heart disease telemonitoring, Health care delivery efficacy, Chronic Diseases Monitoring, Health Services and
Systems, Telehealth, DRE, Health Monitoring, Health Communication, Aging, Monitoring Technology, Health
engagement, Medical innovation, Mobile health, Remote health monitoring, Clinical communication, Medical
communication, Telemedicine, Telehealth, Tele-health, Remote medical support, Telepharmacy, Seniors and health,
Diabetes Monitoring, Telemedicine, Remote patient monitoring, Chronic heart failure mortality, health economics,
Heart Failure, Heart Diseases, Cardiovascular Diseases, Quality of Care, American Medical Group Association,
Department of Veterans Affairs telemonitoring, Chronic disease management, Health Buddy System Healthcare
telemonitoring, Medicare telemonitoring, Bosch telehealth, Treatment Monitoring,

Browse for more products in the same category as this item:

Industry > Healthcare & Pharmaceuticals > Companies - Healthcare & Pharmaceuticals
Wintergreen Research
Regions > Global